A study to assess the efficacy and tolerability of MK0364 in maintaining weight loss induced by diet in obese patients.
Phase of Trial: Phase III
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Taranabant (Primary)
- Indications Obesity
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 08 Apr 2010 Results published in Obesity.
- 12 May 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History